Clinical Trials Browser

Unknown × Pancreatic Neoplasms × Other solid neoplasm × Clear all

Burkitt Lymphoma, Carcinoma, Renal Cell, Esophageal Neoplasms, Glioma, Carcinoma, Hepatocellular, Leukemia, Myeloid, Lung Neoplasms, Lymphoma, Melanoma, Mesothelioma, Multiple Myeloma, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Sarcoma, Synovial, Colorectal Neoplasms

NCT03210298 2019-10-08

PIPACRegis

Unknown

1,000 enrolled

GastrointestinalGynecologicOther solid neoplasmThoracic

Mesothelioma, Malignant, Appendiceal Neoplasms, Ascites, Gallbladder Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Peritoneal Neoplasms, Pleural Effusion, Pseudomyxoma Peritonei, Stomach Neoplasms, Colorectal Neoplasms

NCT02758587 2018-03-19

Study of FAK (Defactinib) and PD-1 (Pembrolizumab) Inhibition in Advanced Solid Malignancies (FAK-PD1)

Phase 1/2 Unknown

59 enrolled

GastrointestinalOther solid neoplasmThoracic

Carcinoma, Non-Small-Cell Lung, Mesothelioma, Pancreatic Neoplasms

NCT02580747 2015-10-20

Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-meso

Phase 1 Unknown

20 enrolled

BreastGastrointestinalGynecologicOther solid neoplasmThoracic

Mesothelioma, Malignant, Ovarian Neoplasms, Pancreatic Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

Clinical Trials

Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies

PIPACRegis

Study of FAK (Defactinib) and PD-1 (Pembrolizumab) Inhibition in Advanced Solid Malignancies (FAK-PD1)

Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-meso